HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis

Keyphrases

• Inflammation 100%
• Mechanistic Insight 100%
• Statins 100%
• Endothelial Progenitor Cells 100%
• HMG-CoA Reductase Inhibitors 100%
• Lipid Profile 66%
• T Cells 33%
• Risk Factors 33%
• Clinical Trials 33%
• Stem Cells 33%
• Beneficial Effects 33%
• Immune Regulation 33%
• Statin Therapy 33%
• Secondary Prevention 33%
• Endothelial Function 33%
• Dual Effect 33%
• Vascular Biology 33%
• Vascular Inflammation 33%
• Endothelial Progenitors 33%
• Inflammation Cells 33%
• Progenitor Stem Cells 33%
• Mechanistic Pathway 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 100%
• Atherosclerosis 100%
• Inflammation 100%
• Clinical Trial 20%
• Statin (Protein) 20%
• Vasculitis 20%